COMMUNIQUÉS West-GlobeNewswire

Cognoa Receives FDA Breakthrough Designations for Autism Diagnostic and Digital Therapeutic Devices
06/02/2019
Company announces first digital therapeutic device and precision health platform to support the developmental and behavioral health of children PALO ALTO, Calif., Feb. 06, 2019 (GLOBE NEWSWIRE) -- Cognoa , a company at [...]
Cerner to Webcast Investment Community Meeting
06/02/2019
KANSAS CITY, Mo., Feb. 06, 2019 (GLOBE NEWSWIRE) -- Cerner (Nasdaq: CERN) announced today that it will host its 2019 Investment Community Meeting on Feb. 13, 2019 and make the live meeting available through a webcast. [...]
Welldoc Submits 510(k) Filing to U.S. Food and Drug Administration to Expand its BlueStar® Digital Therapeutic to Help More Individuals Living with Diabetes
06/02/2019
Welldoc’s chronic disease portfolio grows with new features to support people with both type 1 and type 2 diabetes COLUMBIA, Md., Feb. 06, 2019 (GLOBE NEWSWIRE) -- Welldoc , a leading digital health company, announced [...]
Editas Medicine Names David Scadden, M.D., to Board of Directors
06/02/2019
CAMBRIDGE, Mass., Feb. 06, 2019 (GLOBE NEWSWIRE) -- Editas Medicine, Inc. (NASDAQ: EDIT), a leading genome editing company, today announced that it has appointed David T. Scadden, M.D., to its Board of Directors, [...]
Chemesis Advancing Domestically and Internationally, Plus Exclusive CEO Interview -- CFN Media
06/02/2019
SEATTLE, Feb. 06, 2019 (GLOBE NEWSWIRE) -- CFN Media Group (“CFN Media”), the leading agency and financial media network dedicated to the North American cannabis industry, announces publication of an article and [...]
KLAS ranks Imprivata OneSign as 2019 Single Sign-On Category Leader
06/02/2019
Customers rate Imprivata in 2019 in Best in KLAS: Software & Services Report LEXINGTON, Mass., Feb. 06, 2019 (GLOBE NEWSWIRE) -- Imprivata® , the healthcare IT security company, today announced that Imprivata [...]
Indiva Shapes Strong Brand Identity in Canada, Eyes Emerging European Market -- CFN Media
06/02/2019
SEATTLE, Feb. 06, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- CFN Media Group (“CFN Media”), the leading agency and financial media network dedicated to the North American cannabis industry, announces publication of an [...]
Marrone Bio Innovations’ almond bloom solutions increase farmer ROI and support new Almond Orchard 2025 Goals
06/02/2019
DAVIS, Calif., Feb. 06, 2019 (GLOBE NEWSWIRE) -- Marrone Bio Innovations Inc. (NASDAQ: MBII) (MBI), a leading developer of biological crop protection and plant health solutions, is offering a pair of products – Haven ® [...]
FSD Pharma Looks to Grow Cannabinoids in Algae -- CFN Media
06/02/2019
SEATTLE, Feb. 06, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- CFN Media Group (“CFN Media”), the leading agency and financial media network dedicated to the North American cannabis industry, announces publication of an [...]
resTORbio Appoints Erkan Baloglu, Ph.D., M.B.A., as Vice President of Drug Discovery and Medicinal Chemistry
06/02/2019
BOSTON, Feb. 06, 2019 (GLOBE NEWSWIRE) -- resTORbio, Inc. (Nasdaq:TORC), a clinical-stage biopharmaceutical company developing a new class of medicines that target the biology of aging to prevent or treat age-related [...]
Corvus Presents Updated Biomarker and Clinical Results from Lead Pipeline Programs CPI-444 and CPI-006 at Immuno-Oncology 360° Conference
06/02/2019
BURLINGAME, Calif., Feb. 06, 2019 (GLOBE NEWSWIRE) -- Corvus Pharmaceuticals, Inc. (Nasdaq: CRVS), a clinical-stage biopharmaceutical company focused on the development and commercialization of precisely targeted [...]
Eyenovia Announces FDA Acceptance of IND Application for MicroPine to Reduce the Progression of Myopia
06/02/2019
On track to initiate Phase III trial in H1 2019 NEW YORK, Feb. 06, 2019 (GLOBE NEWSWIRE) -- Eyenovia, Inc. (NASDAQ: EYEN), a clinical stage ophthalmic biopharmaceutical company developing a pipeline of microdose [...]
ChemioCare Reports Positive Animal Study Results for CMIO-Ondan Patch
06/02/2019
NEW YORK, Feb. 06, 2019 (GLOBE NEWSWIRE) -- ChemioCare USA Inc. (“ChemioCare” or the “Company”), a platform company based on proprietary transdermal delivery, today announced the minipig safety and pharmacokinetic study [...]
Stryker declares a $0.52 per share quarterly dividend
06/02/2019
Kalamazoo, Michigan, Feb. 06, 2019 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) announced that its Board of Directors has declared a quarterly dividend of $0.52 per share payable on April 30, 2019 to shareholders of record at [...]
Bionano Genomics’ Saphyr® System Used for Highly Accurate Detection of the Genetic Disorder FSHD as an Alternative to Southern Blot
06/02/2019
Efforts to Validate Saphyr for Digital Cytogenetics are Accelerating SAN DIEGO, Feb. 06, 2019 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (NASDAQ: BNGO), a life sciences instrumentation company that develops and markets [...]
Fibrocell to Present at 21st Annual BIO CEO & Investor Conference
06/02/2019
EXTON, Pa., Feb. 06, 2019 (GLOBE NEWSWIRE) -- Fibrocell Science, Inc. (NASDAQ: FCSC), a gene therapy company focused on transformational autologous cell-based therapies for skin and connective tissue diseases, today [...]
Zogenix Submits New Drug Application to U.S. Food & Drug Administration and Marketing Authorization Application to European Medicines Agency for FINTEPLA® for the Treatment of Dravet Syndrome
06/02/2019
EMERYVILLE, Calif., Feb. 06, 2019 (GLOBE NEWSWIRE) -- Zogenix, Inc. (NASDAQ:ZGNX), a global pharmaceutical company developing rare disease therapies, today announced it has completed its rolling submission of a New Drug [...]
Rexahn Announces Presentations at the 2019 ASCO Genitourinary Cancers Symposium
06/02/2019
ROCKVILLE, Md., Feb. 06, 2019 (GLOBE NEWSWIRE) -- Rexahn Pharmaceuticals, Inc. (NYSE American: RNN), a clinical stage biopharmaceutical company developing innovative therapies to improve patient outcomes in cancers that [...]
BioVie Completes Patient Enrollment for its Phase 2a Clinical Trial of BIV201 in Refractory Ascites
06/02/2019
LOS ANGELES, Feb. 06, 2019 (GLOBE NEWSWIRE) -- BioVie Inc. (OTCQB: BIVI) (“BioVie” or the “Company”), a clinical-stage company developing innovative drug therapies for liver disease, announced today that it has [...]

Pages